ProtoKinetix, Incorporated

PKTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-1.5M $-1.5M $-1.3M $-168.5K $-448.6K $-197.1K $-1.2M $-1.4M
Depreciation & Amortization — — — — — — — —
Depreciation — — — — $0 $0 $0 $0
Amortization $3.0K $3.0K $1.5K — — — — —
Stock-Based Compensation $910.4K $760.1K $531.5K — — — — —
Net Cash from Operating Activities $-605.1K $-820.3K $-574.2K $-229.2K $-105.3K $-149.9K $-396.6K $-114.9K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $57.0K $-29.8K $-46.8K $30.0K $25.0K $0 $0 $0
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $480.0K $850.0K $991.8K $196.5K $81.0K $147.8K $386.7K $106.5K
Net Change in Cash $-68.1K $-43 $370.8K $-2.7K $659 $-2.1K $-9.9K $-8.4K
Free Cash Flow — — — — — — — —
← Newer Page 2 of 2 Older →